Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
TJX Companies
TJX
$155B
| $78.7M | 0.05% |
1,193,058
+225,881
| +23% | +$15.8M |
|
402
Union Pacific
UNP
$183B
| $78.4M | 0.05% |
399,942
-210,545
| -34% | -$45.5M |
|
403
CALL
Chevron
CVX
$403B
| $78.3M | 0.05% |
772,100
-152,700
| -17% | -$15.2M |
|
404
CALL
Teladoc Health
TDOC
$1.16B
| $78M | 0.05% |
614,900
+459,000
| +294% | +$66.8M |
|
405
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $77.9M | 0.05% |
612,000
+460,000
| +303% | +$60.8M |
|
406
CALL
Advanced Micro Devices
AMD
$773B
| $77.7M | 0.05% |
754,900
+490,900
| +186% | +$50.2M |
|
407
PUT
T-Mobile US
TMUS
$196B
| $77.6M | 0.05% |
607,700
-15,500
| -2% | -$2.16M |
|
408
Ally Financial
ALLY
$13.1B
| $77.3M | 0.05% |
1,513,782
+966,474
| +177% | +$50M |
|
409
PUT
Caterpillar
CAT
$381B
| $77.2M | 0.05% |
402,300
+155,700
| +63% | +$32.4M |
|
410
Abbott
ABT
$202B
| $77M | 0.05% |
651,802
-426,093
| -40% | -$52.3M |
|
411
Northrop Grumman
NOC
$78.3B
| $76.9M | 0.05% |
213,601
-61,935
| -22% | -$22.4M |
|
412
Biogen
BIIB
$32B
| $76.9M | 0.05% |
271,819
-35,210
| -11% | -$11.5M |
|
413
CALL
Manulife Financial
MFC
$70.5B
| $76.8M | 0.05% |
+3,150,000
| New | +$61.2M |
|
414
Pultegroup
PHM
$24.6B
| $76.6M | 0.05% |
1,667,405
+170,940
| +11% | +$8.88M |
|
415
Halliburton
HAL
$29.4B
| $76.1M | 0.05% |
3,518,037
+435,356
| +14% | +$8.92M |
|
416
Invitation Homes
INVH
$17.9B
| $75.9M | 0.05% |
1,980,521
-2,309,773
| -54% | -$92.6M |
|
|
NVO
417
Novo Nordisk
NVO
$207B
| $75.8M | 0.05% |
1,578,784
+1,554,634
| +6,437% | +$75.2M |
|
418
PUT
Thermo Fisher Scientific
TMO
$233B
| $75.2M | 0.05% |
131,600
+3,100
| +2% | +$1.7M |
|
419
CALL
Merck
MRK
$376B
| $75.2M | 0.05% |
+1,105,100
| New | +$84M |
|
420
Reinsurance Group of America
RGA
$15.9B
| $75.1M | 0.05% |
674,876
+508,080
| +305% | +$57.9M |
|
421
CALL
PayPal
PYPL
$52.7B
| $75M | 0.05% |
288,400
+133,300
| +86% | +$37.8M |
|
422
PUT
Intuitive Surgical
ISRG
$134B
| $75M | 0.05% |
226,200
-33,000
| -13% | -$11.1M |
|
423
PUT
Baidu
BIDU
$31.6B
| $74.5M | 0.04% |
484,800
+248,000
| +105% | +$40.7M |
|
424
CALL
FedEx
FDX
$76.9B
| $74.5M | 0.04% |
339,800
+268,900
| +379% | +$73M |
|
425
CALL
Target
TGT
$75.1B
| $74.4M | 0.04% |
325,200
+117,500
| +57% | +$29.4M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.